The Australian Hepatitis and risk survey in prisons (AusHep) is a national prison-based blood-borne virus (BBV) surveillance study. This biobehavioural survey involves point-of-care testing for hepatitis C (HCV) antibodies and RNA (if antibody positive), hepatitis B surface antigens, hepatitis B surface antibodies, and HIV surface antibodies, and an interview-style survey on prior testing and treatment history and engagement in risk behaviours. The study will recruit approximately 2400 prisoner participants from 25 representative prisons across Australia, annually.
Study Type
OBSERVATIONAL
Enrollment
2,400
Qualitative point-of-care test for hepatitis C antibodies (saliva sample)
Hepatitis C Viral Load point-of-care test (fingerstick wholeblood sample)
Qualitative hepatitis B surface antibody point-of-care test (fingerstick wholeblood sample)
The prevalence of HCV in Australian prisons
This is estiamted by perfroming the HCV antibody test and HCV RNA viral load test on a representative prison population.
Time frame: 1 Year
The prevalance of HBV in Australian prisons
This is estimated by performing the HBV surface antigen test on a respresentative prison population
Time frame: 1 year
The prevalance of HIV in Australian prisons
This is estimated by performing the HIV antibody test on a respresentative prison population.
Time frame: 1 year
The proportion of individuals who are engaged in each step of HBV and HCV care cascades
This is estimated by conducting the bio-behavioural survey.
Time frame: 1 Year
The prevalence of risk behaviours and harm reduction access
The risk behavrious and harm reduction measures include injecting and non-injecting drug use, high risk injecting practices, sexual risk behaviours, tattooing; and bleach or opioid substitution therapy (OST) uptake. This is estimated by conducting the bio-behavioural survey.
Time frame: 1 Year
The factors associated with HCV and HBV infection investigated by the bio-behavioural survey.
Time frame: 1 Year
The factors associated with engaging in each step of HCV and HBV care cascades and HBV vaccination investigated by the bio-behavioural survey.
Time frame: 1 Year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Qualitative hepatitis B surface antigen point-of-care test (fingerstick wholeblood sample)
Qualitative HIV antibody point-of-care test (saliva sample)
Interview-style survey regarding demographics, risk behaviours, BBV testing and treatment history, and point-of-care testing acceptability
Alexander Maconochie Centre
Hume, Australian Capital Territory, Australia
NOT_YET_RECRUITINGBathurst Correctional Complex
Bathurst, New South Wales, Australia
COMPLETEDJohn Morony Correctional Complex
Berkshire Park, New South Wales, Australia
COMPLETEDCessnock Correctional Centre
Cessnock, New South Wales, Australia
COMPLETEDMid North Coast Correctional Centre
Kempsey, New South Wales, Australia
COMPLETEDSouth Coast Correctional Centre
Nowra, New South Wales, Australia
COMPLETEDSilverwater Women's Correctional Centre
Silverwater, New South Wales, Australia
COMPLETEDWellington Correctional Centre
Wuuluman, New South Wales, Australia
COMPLETEDAlice Springs Correctional Centre
Alice Springs, Northern Territory, Australia
NOT_YET_RECRUITINGDarwin Correctional Centre
Howard Springs, Northern Territory, Australia
NOT_YET_RECRUITING...and 14 more locations